TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Actelion Pharmaceuticals Sverige AB
Closing information (x1000 NOK)
Closing information | 2018/12 | 2017/12 | 2016/12 |
Turnover | 252,805 | 249,582 | 212,746 |
Financial expenses | 2,052 | 3,117 | 37 |
Earnings before taxes | 10,319 | 16,567 | 9,605 |
EBITDA | 10,264 | 18,674 | 5,740 |
Total assets | 179,976 | 161,175 | 130,217 |
Current assets | 179,729 | 160,505 | 129,360 |
Current liabilities | 127,836 | 112,180 | 94,260 |
Equity capital | 52,140 | 48,995 | 33,190 |
- share capital | 976 | 999 | 950 |
Employees (average) | 29 | 28 | 29 |
Financial ratios
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Solvency | 29.0% | 30.4% | 25.5% |
Turnover per employee | 8,717 | 8,914 | 7,336 |
Profit as a percentage of turnover | 4.1% | 6.6% | 4.5% |
Return on assets (ROA) | 6.9% | 12.2% | 7.4% |
Current ratio | 140.6% | 143.1% | 137.2% |
Return on equity (ROE) | 19.8% | 33.8% | 28.9% |
Change turnover | 8,954 | 25,796 | 7,519 |
Change turnover % | 4% | 12% | 4% |
Chg. No. of employees | 1 | -1 | 1 |
Chg. No. of employees % | 4% | -3% | 4% |
Total value of public sale
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.